Ambey Laboratories Share Price
Start SIP in Ambey Laboratories
Start SIPAmbey Laboratories Performance
Day Range
- Low 66
- High 70
52 Week Range
- Low 61
- High 97
- Open Price70
- Previous Close70
- Volume98000
Ambey Laboratories Investment Rating
-
Master Rating:
-
Ambey Laboratories Ltd has an operating revenue of Rs. 271.16 Cr. on a trailing 12-month basis. An annual revenue growth of 26% is outstanding, Pre-tax margin of 6% is okay, ROE of 34% is exceptional. The company has a debt to equity of 97%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 4 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 57 indicates it belongs to a fair industry group of Diversified Operations and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Mar 2023 |
---|---|
Total Revenue Annual Cr | 107 |
Operating Expenses Annual Cr | 96 |
Operating Profit Annual in Cr | 8 |
Depreciation Cr | 3 |
Interest Annual Cr | 2 |
Tax Annual Cr | 2 |
Net Profit Annual Cr | 5 |
Ambey Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹73.01
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹74.58
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
Ambey Laboratories Resistance and Support
Resistance | |
---|---|
First Resistance | 69.73 |
Second Resistance | 72.27 |
Third Resistance | 74.13 |
RSI | 36.01 |
MFI | 23.72 |
MACD Single Line | -1.49 |
MACD | -1.73 |
Support | |
---|---|
First Support | 65.33 |
Second Support | 63.47 |
Third Supoort | 60.93 |
Ambey Laboratories Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 98,000 | 8,199,660 | 83.67 |
Week | 50,800 | 3,679,952 | 72.44 |
1 Month | 125,818 | 8,963,287 | 71.24 |
6 Month | 105,252 | 8,543,307 | 81.17 |
Ambey Laboratories Result Highlights
Ambey Laboratories Synopsis
NSE-Diversified Operations
Ambey Laboratories belongs to the Industry of Agro Chemicals/Pesticides. Company’s Total Operating Revenue is Rs. 104.82 Cr. and Equity Capital is Rs. 17.75 Cr. for the Year ended 31/03/2023. Ambey Laboratories Ltd. is a Public Limited Listed company incorporated on 20/03/1985 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is U74899DL1985PLC020490 and registration number is 020490.Market Cap | 177 |
Sales | 105 |
Shares in Float | 0.75 |
No of funds | |
Yield |
Book Value | 0.96 |
U/D Vol ratio | 0.6 |
LTDebt / Equity | 97 |
Alpha | -0.53 |
Beta | 0.97 |
Ambey Laboratories Shareholding Pattern
Owner Name |
---|
Ambey Laboratories Management
Name | Designation |
---|---|
Mrs. Sarina Gupta | Whole Time Director |
Mrs. Rishita Gupta | Non Executive Director |
Mr. Sandeep Bansal | Non Executive Director |
Mr. Abdul Quadir | Independent Director |
Ms. Roni Soni | Independent Director |
Mr. Sarvar Alam | Chief Financial Officer |
Ms. Rimple Sarin | Co. Secretary & Compl. Officer |
Ambey Laboratories Forecast
Price Estimates
Ambey Laboratories FAQs
What is Share Price of Ambey Laboratories ?
Ambey Laboratories share price is ₹67 As on 18 September, 2024 | 02:26
What is the Market Cap of Ambey Laboratories ?
The Market Cap of Ambey Laboratories is ₹167.6 Cr As on 18 September, 2024 | 02:26
What is the P/E ratio of Ambey Laboratories ?
The P/E ratio of Ambey Laboratories is As on 18 September, 2024 | 02:26
What is the PB ratio of Ambey Laboratories ?
The PB ratio of Ambey Laboratories is 12.8 As on 18 September, 2024 | 02:26